Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β.
Chaudhry K, Geiger A, Dowlati E, Lang H, Sohai DK, Hwang EI, Lazarski CA, Yvon E, Holdhoff M, Jones R, Savoldo B, Cruz CRY, Bollard CM. Chaudhry K, et al. Among authors: holdhoff m. Mol Ther Methods Clin Dev. 2022 Oct 21;27:415-430. doi: 10.1016/j.omtm.2022.10.010. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36381305 Free PMC article.
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
Holdhoff M, Nicholas MK, Peterson RA, Maraka S, Liu LC, Fischer JH, Wefel JS, Fan TM, Vannorsdall T, Russell M, Iacoboni M, Tarasow TM, Hergenrother PJ, Dudek AZ, Danciu OC. Holdhoff M, et al. Neurooncol Adv. 2023 Jul 19;5(1):vdad087. doi: 10.1093/noajnl/vdad087. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37554223 Free PMC article.
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies.
Goodday SM, Karlin E, Brooks A, Chapman C, Harry C, Lugo N, Peabody S, Rangwala S, Swanson E, Tempero J, Yang R, Karlin DR, Rabinowicz R, Malkin D, Travis S, Walsh A, Hirten RP, Sands BE, Bettegowda C, Holdhoff M, Wollett J, Szajna K, Dirmeyer K, Dodd A, Hutchinson S, Ramotar S, Grant RC, Boch A, Wildman M, Friend SH. Goodday SM, et al. Among authors: holdhoff m. J Med Internet Res. 2024 Sep 3;26:e57827. doi: 10.2196/57827. J Med Internet Res. 2024. PMID: 39226552 Free PMC article.
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S. Horbinski C, et al. Among authors: holdhoff m. J Natl Compr Canc Netw. 2023 Jan;21(1):12-20. doi: 10.6004/jnccn.2023.0002. J Natl Compr Canc Netw. 2023. PMID: 36634606
Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.
Sloan L, Sen R, Liu C, Doucet M, Blosser L, Katulis L, Kamson DO, Grossman S, Holdhoff M, Redmond KJ, Quon H, Lim M, Eberhart C, Pardoll DM, Hu C, Ganguly S, Kleinberg LR. Sloan L, et al. Among authors: holdhoff m. Front Immunol. 2024 Sep 13;15:1438044. doi: 10.3389/fimmu.2024.1438044. eCollection 2024. Front Immunol. 2024. PMID: 39346903 Free PMC article.
ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.
Zhang KY, Parker M, Weber-Levine C, Kalluri A, Gonzalez-Gomez I, Raabe E, Dudley JC, Gocke C, Lin MT, Zou Y, Sherief M, Kamson DO, Holdhoff M, Mukherjee D, Croog V, Schreck KC, Rincon-Torroella J, Bettegowda C, Eberhart CG, Bale T, Lucas CG. Zhang KY, et al. Among authors: holdhoff m. Acta Neuropathol. 2024 Aug 14;148(1):19. doi: 10.1007/s00401-024-02785-z. Acta Neuropathol. 2024. PMID: 39141113 Free PMC article. No abstract available.
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR).
Ahluwalia MS, Ozair A, Rudek M, Ye X, Holdhoff M, Lieberman FS, Piotrowski AF, Nabors B, Desai A, Lesser G, Huang RC, Glenn S, Khosla AA, Peereboom DM, Wen PY, Grossman SA. Ahluwalia MS, et al. Among authors: holdhoff m. Cell Rep Med. 2024 Jul 16;5(7):101630. doi: 10.1016/j.xcrm.2024.101630. Epub 2024 Jul 1. Cell Rep Med. 2024. PMID: 38955178 Free PMC article. Clinical Trial.
115 results